Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes

By Matikainen Niina   Taskinen Marja-Riitta  

Future Lipidology, Vol. 3, Iss. 5, 2008-10 ,pp. : 531-543

Future Medicine

Access to resources Recommend Favorite

Triglyceride-rich lipoproteins and endothelial dysfunction: molecular mechanisms and gene expression studies

By Norata Giuseppe Danilo   Catapano Alberico Luigi  

Future Lipidology, Vol. 2, Iss. 2, 2007-04 ,pp. : 119-122

Future Medicine

Access to resources Recommend Favorite

Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients

By Derosa Giuseppe   Maffioli Pamela   Salvadeo Sibilla A. T.   Ferrari Ilaria   Gravina Alessia   Mereu Roberto   Palumbo Ilaria   D'angelo Angela   Cicero Arrigo F. G.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1973-1983

Informa Healthcare

Access to resources Recommend Favorite

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study

By Goldstein Barry J.   Weissman Peter N.   Wooddell Margaret J.   Waterhouse Brian R.   Cobitz Alexander R.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1715-1723

Informa Healthcare

Access to resources Recommend Favorite

Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo

By Heeren Joerg   Niemeier Andreas   Merkel Martin   Beisiegel Ulrike  

Journal of Molecular Medicine, Vol. 80, Iss. 9, 2002-09 ,pp. : 576-584

Springer Publishing Company

Access to resources Recommend Favorite